Listed

ImmunityBio, Inc.: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Mar 4, 2021 and accepted by EDGAR at Mar 4, 2021, 16:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-10-01 to 2020-12-31$21.0kus-gaap:Revenues
Revenue12 months2020-01-01 to 2020-12-31$111.0kus-gaap:Revenues
Research and development12 months2020-01-01 to 2020-12-31$64.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2020-01-01 to 2020-12-31$27.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-10-01 to 2020-12-31−$30.9mus-gaap:OperatingIncomeLoss
Operating income12 months2020-01-01 to 2020-12-31−$91.6mus-gaap:OperatingIncomeLoss
Income tax12 months2020-01-01 to 2020-12-31$5.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-10-01 to 2020-12-31−$32.1mus-gaap:NetIncomeLoss
Net income12 months2020-01-01 to 2020-12-31−$92.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-10-01 to 2020-12-31−$0.30us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2020-01-01 to 2020-12-31−$70.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$2.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2020-01-01 to 2020-12-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-12-31$11.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$75.5mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$151.9mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$24.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$34.5mus-gaap:Liabilities
Shareholders' equityAt period end2020-12-31$117.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-21-010945. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.